₹14,550(30 Shares)
Minimum Investment
IPO Dates
Oct 9, 2025 – Oct 13, 2025
Price Band
₹461–485 per equity share
Lot Size
30
Listing
Oct 16, 2025
Listing At
BSE, NSE
NII Sub-Categories
bHNI (> ₹10L)
Bids above ₹10L
sHNI (< ₹10L)
Bids ₹2L to ₹10L
Overall Subscription
Total Bids Received
109.33x
Shares Offered
42,54,299
Shares Offered
85,06,804
Shares Offered
1,27,64,691
Founded in 1999, Rubicon Research Limited is a pharmaceutical organization that deals with the development, manufacturing, and marketing of differentiated formulation.As of March 31, 2024, Rubicon Res...
EPS (Pre-IPO)
8.70
EPS (Post-IPO)
10.51
P/E (Pre-IPO)
55.75
P/E (Post-IPO)
46.13
RoNW
29.02%
PAT Margin
10.37%
Market Cap
7990.21 Cr.
* All figures are in ₹ Crores unless otherwise stated.
MedOne House, B-75, Road No. 33, Wagle Estate, Thane West-400604, Maharashtra, India Thane, Maharashtra, 400604
MUFG Intime India Private Limited (Link Intime)
The Rubicon Research Limited IPO price band is set at ₹461.00 to ₹485.00 per equity share.
The lot size for Rubicon Research Limited IPO is 30 shares per lot. The minimum investment amount is approximately ₹14,550.
The Rubicon Research Limited IPO opens on Oct 9, 2025 and closes on Oct 13, 2025.
Rubicon Research Limited IPO is expected to be listed on Oct 16, 2025 on BSE, NSE.
The current GMP for Rubicon Research Limited IPO is ₹140, suggesting an expected listing price of around ₹601.00. Note: GMP is an unofficial market indicator.
The registrar for Rubicon Research Limited IPO is MUFG Intime India Private Limited (Link Intime). You can contact them at rubicon.ipo@linkintime.co.in.